// App-Quantinova.ai

4666 : Prognostic Factors for Late Mortality Among Day 100 Survivors after Allogeneic Hematopoietic Cell Transplantation (HCT)

Researchers

Presenter

  • Sagar S. Patel

Principal Investigators

  • Lisa Rybicki

  • Donna Abounader

  • Brad Pohlman

  • Ronald Sobecks

  • Navneet S. Majhail

  • Betty K. Hamilton

  • Brian J. Bolwell

  • Robert Dean

  • Hien K. Liu

  • Aaron T. Gerds

  • Rabi Hanna

  • Brian T. Hill

  • Deepa Jagadeesh

  • Matt Kalaycio

Medical Centers

  • Hematology & Oncology, Cleveland Clinic, Cleveland, OH

  • Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

  • Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Alpha-thalassemia myelodysplasia syndrome

  • Chronic Myelogenous Leukemia

  • Acute myelocytic leukemia

Biomarkers

  • Hematocrit

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved